Internal Medicine, Endocrinology, Diabetes, & Metabolism · New Braunfels, TX
NPI
1407843972
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1770 State Highway 46 W
New Braunfels, TX, 78132
Phone (830) 730-4375
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,107 services
Medicare patients, 2024
336
Average age 73
Drug cost, 2024
$2.0M
3,803 prescriptions
Company payments, 2025
$2,219
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arindam Bandyopadhyay was code 99214 (office e&m - established), 417 times for 174 patients. In total Arindam Bandyopadhyay billed 1,107 services in 16 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 417 | 174 | $87.17 | $36K |
| 95251 Test - Miscellaneous | Office | 208 | 100 | $25.32 | $5,266 |
| 99204 Office E&M - New | Office | 156 | 156 | $126.17 | $20K |
| 82962 Clinical Chemistry | Office | 141 | 72 | $3.19 | $450 |
| 99203 Office E&M - New | Office | 39 | 39 | $81.49 | $3,178 |
| 99213 Office E&M - Established | Office | 37 | 35 | $59.28 | $2,194 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 34 | 31 | $12.52 | $426 |
| 95249 Test - Miscellaneous | Office | 32 | 29 | $49.26 | $1,576 |
| 36415 Venipuncture Blood Collection | Office | 12 | 12 | $5.88 | $70.56 |
By year: 2022 $54K for 698 services; 2023 $88K for 1,277 services; 2024 $73K for 1,107 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 141 | 72 | $3.19 | $450 |
| 36415 Venipuncture Blood Collection | 12 | 12 | $5.88 | $70.56 |
Medicare prescription drug claims, 2024
In 2024, the drug Arindam Bandyopadhyay prescribed most often to Medicare patients was Ozempic (Semaglutide), with 453 prescriptions and refills. In total Arindam Bandyopadhyay wrote 3,803 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 453 | 635 | 89 | $589K |
| Metformin Hcl Generic | 314 | 891 | 118 | $3,086 |
| Levothyroxine Sodium Generic | 272 | 740 | 93 | $3,565 |
| Pioglitazone Hcl Generic | 269 | 769 | 89 | $3,688 |
| Jardiance Empagliflozin | 196 | 484 | 67 | $264K |
| Atorvastatin Calcium Generic | 181 | 521 | 71 | $2,236 |
| Rosuvastatin Calcium Generic | 128 | 363 | 51 | $1,831 |
| Mounjaro Tirzepatide | 114 | 138 | 22 | $145K |
| Losartan Potassium Generic | 107 | 307 | 45 | $1,017 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 101 | 229 | 37 | $13K |
| Tresiba Flextouch U-100 Insulin Degludec | 93 | 246 | 36 | $55K |
| Lisinopril Generic | 85 | 254 | 38 | $668 |
| Farxiga Dapagliflozin Propanediol | 75 | 161 | 20 | $87K |
| Metformin Hcl Er Metformin Hcl | 75 | 196 | 28 | $850 |
| Alendronate Sodium Generic | 72 | 203 | 29 | $643 |
Brand drugs: 1,667 claims; generic drugs: 2,017 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arindam Bandyopadhyay $2,219 ($2,219 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $357.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 18 | $357 |
| Amgen Inc. AMGN | 10 | $216 |
| Lilly USA, LLC LLY | 9 | $197 |
| Corcept Therapeutics CORT | 8 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $135 |
| Recordati_rare_diseases_inc. | 6 | $118 |
| Beta Bionics, Inc. BBNX | 7 | $107 |
| Sequel Med Tech, LLC | 5 | $105 |
| Esperion Therapeutics, Inc. ESPR | 5 | $102 |
| Averitas Pharma Inc. | 5 | $98.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.